Strengthening Interactions between Statisticians and Collaborators: Objectives and Sample Sizes
暂无分享,去创建一个
[1] Larry Rubinstein,et al. Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee , 2010, Clinical Cancer Research.
[2] David J. Kupfer,et al. Size of Treatment Effects and Their Importance to Clinical Research and Practice , 2006, Biological Psychiatry.
[3] Ameet Bakhai,et al. Sample size determination for clinical research. , 2013, Muscles, ligaments and tendons journal.
[4] S. Pocock,et al. Clinical trials with multiple outcomes: a statistical perspective on their design, analysis, and interpretation. , 1997, Controlled clinical trials.
[5] Douglas G Altman,et al. Dichotomizing continuous predictors in multiple regression: a bad idea , 2006, Statistics in medicine.
[6] Larry Rubinstein,et al. Randomized Phase II Designs , 2009, Clinical Cancer Research.
[7] M. Bhandari,et al. Why perform a priori sample size calculation? , 2013, Canadian journal of surgery. Journal canadien de chirurgie.
[8] Ulrich Mansmann,et al. Sample size determinations in original research protocols for randomised clinical trials submitted to UK research ethics committees: review , 2013, BMJ.
[9] K. Schulz,et al. Sample size calculations in randomised trials: mandatory and mystical , 2005, The Lancet.